期刊文献+

影响胸管引流联合硬化剂治疗恶性胸腔积液疗效的多因素分析 被引量:3

Multi-factor analysis of the curative effect of thoracic drainage and intrapleural injection of adhesion agent in the treatment of the malignant pleural effusion
原文传递
导出
摘要 目的 观察胸管引流联合硬化剂治疗恶性胸腔积液(MPE)的疗效,并探讨其影响因素.方法 回顾性分析196例实施胸管引流并行硬化剂胸膜粘连的MPE患者的临床资料.将性别、年龄、KPS评分、原发肿瘤的组织来源、胸水部位、胸水中细胞数、蛋白值、LDH值、硬化剂的种类、使用硬化剂前24 h的胸水引流量、胸膜固定术后继续引流至拔管的时间等11个因素作为研究对象,分析影响疗效的因素.结果 196例患者中,治疗后显效61例,有效71例,无效64例,总有效率67.3%.单因素分析表明,患者的KPS评分、原发肿瘤的组织来源、胸水部位、胸水蛋白值、LDH值、硬化剂的种类、使用硬化剂前24 h的胸水引流量与疗效相关(x2=6.55、11.95、6.93、9.05、14.58、10.57、13.44,均P<0.05).多因素Logistic回归分析又显示:KPS评分、原发肿瘤的组织来源、硬化剂的种类、使用硬化剂前24h的胸水引流量是影响疗效的独立因素(OR值=1.78、2.12、11.40、6.30,均P<0.05).结论 KPS评分≥70分、原发于乳腺癌、使用注射用A群链球菌(沙培林)作为硬化剂、使用硬化剂前24 h的胸水引流量≤200 mL的MPE患者,粘连疗效较好. Objective To study the effect of chest drainage and injection of pleural adhesion agent in the treatment of the malignant pleural effusion (MPE),and to discuss the influences about it.Methods The data of the in-hospital patients with MPE who received thoracostomic drainage and pleural adhesions were retrospectively analyzed.11 factors were selected as research subjects,such as sex,age,KPS score,tissue origin of primary tumor,the position of hydrothorax,the cell number,the level of protein,the level of LDH in the effusion,species of sclerosant,the fluid volume of hydrothorax in 24 hours before using sclerosant,the duration between pleurodesis and removing the tude.Then,the factors that affected the effect of pleurodesis were analyzed.Results In total 196 cases,61 patients acquired significant efficacy,71 men achieved good result,and 64 people had no effect.The total effective rate was 67.3%.Univariate analysis showed that KPS score,tissue origin of primary tumor,the position of hydrothorax,the level of protein and LDH in the effusion,species of sclerosant,the fluid volumeof hydrothorax in 24 hours before using sclerosant were related to the effect.Multivariate Logistic regression analysis indicated that KPS score,tissue origin of primary tumor,the position of hydrothorax,the level of protein and LDH in the effusion,species of sclerosant,the fluid volume of hydrothorax in 24 hours before using sclerosant were indepent factors for efficacy of the pleurodesis.Conclusion It seems that good adhesion effect achieved in patients with MPE that KPS score ≥70,primary breast carcinoma,using sapylin as a sclerosant,the fluid volume of hydrothorax ≤ 200nmL in 24 hours before using sclerosant.
出处 《中国基层医药》 CAS 2015年第3期388-391,共4页 Chinese Journal of Primary Medicine and Pharmacy
关键词 胸腔积液 恶性 引流术 硬化溶液 因素分析 统计学 Pleural effusion,malignant Drainage Sclerosant solutions Factor analysis,statistical
  • 相关文献

参考文献4

二级参考文献47

  • 1童朝辉,王臻,王辰.内科胸腔镜技术及其临床应用[J].中华结核和呼吸杂志,2007,30(3):220-222. 被引量:86
  • 2刘相燕,王洲,刘凡英,王功朝,刘颖.胸腔镜下胸膜腔闭锁术治疗恶性胸腔积液的临床评价[J].中华肿瘤防治杂志,2007,14(12):946-947. 被引量:17
  • 3林殿杰 滕维生 等.简易负压抽吸器治疗气胸的初步观察[J].实用肺科杂志,1997,3:48-49.
  • 4Parulekar W, Drimio GD, Motzinger F, et al. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions[ J ]. Chest, 2001, ( 1 ) : 19.
  • 5Viallat JR, Rey F, Astoul P, et al. Thoracoscopy talc poudrage pleurodesis for malignant effusions [ J ]. Chest, 1996, 110 ( 6 ) :1387.
  • 6Weissberg D. Talc pleurodesis: a controversial issue[ J ]. Poumon Caeur, 1981,37: 291.
  • 7Aelony Y, King R, Boutin C. Thoracoscopic talc poudrage pleurodesis for chronic recurrent pleural effusions [ J ]. Anel Intern Med, 1991,115 : 778 - 782.
  • 8Heller BJ, Grathwohl MK. Contralateral reexpansion pulmonary edema[J]. South Med J, 2000,93(8):828.
  • 9Viskum K, Lange P, Mortenson J. Long term sequelae after talc pleurodesis for spontaneous pneumothorax [J]. Pneumologie,1989,43:105.
  • 10Cardillo G,Facciolo F,Carbone L,et al.Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions[J].Eur J Cardiothorac Surg,2002,21(2):302-305.

共引文献218

同被引文献30

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部